|
Leucogen
|
-
|
EU/2/09/096/001
|
Virbac S.A., Francija
|
QI06AA01
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated feline leukaemia virus
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Virbac S.A., Francija
|
| Date of authorisation/renewal: |
12-Jun-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/09/096/001 |
|
10 |
Stikla flakons, 1 ml |
-
|
|
|
Simparica Trio
|
mg
|
EU/2/19/243/012
|
Zoetis Belgium S.A., Beļģija
|
QP54AB52
|
Dogs > 10-20 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Sarolaner, Moxidectin, Pyrantel embonate
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Corden Pharma GmbH, Vācija
|
| Date of authorisation/renewal: |
17-Sep-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/243/012 |
|
6 |
Alumīnija folija blisteris, 1 tablete |
-
|
|
|
Firocoxib CP-Pharma
|
57 mg
|
EU/2/25/359/005
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
26-Jan-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/359/005 |
|
100 |
alumīnija/PVC/PE/PVDC blisteris, 10 tablete |
-
|
|
|
Loxicom
|
2.5 mg
|
EU/2/08/090/025
|
Norbrook Laboratories (Ireland) Limited, Īrija
|
QM01AC06
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Meloxicam
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Norbrook Laboratories Limited, Lielbritānija
|
| Date of authorisation/renewal: |
12-Mar-2014
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/08/090/025 |
2,5 mg |
10 |
Blisteris, 10 tablete |
-
|
|
|
Nobivac RL
|
-
|
V/I/25/0007
|
Intervet International B.V., Nīderlande
|
QI07AL01
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
suspension for injection
|
| International name (active substance): |
Inactivated rabies virus strain Pasteur RIV, Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated, Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain 820K, Inactivated
|
| Distribution category: |
To be used only by veterinary surgeon
|
| Manufacturer(s) responsible for batch release |
Intervet International Booxmer, Nīderlande
|
| Date of authorisation/renewal: |
19-Mar-2025
|
| Marketing authorisation valid until: |
18-Mar-2030
|
| Marketing authorisation procedure: |
I
|
| Package leaflet: |
[DOCX] 19032025LI (19-Mar-2025)
|
| Labelling text: |
See products section
|
| Summary of product characteristics: |
-
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| V/I/25/0007-01 |
|
10 |
Stikla flakons, 1 deva |
[PDF]
|
|
|
FRONTPRO
|
28.3 mg
|
EU/2/19/240/007
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QP53BE01
|
Dogs >4–10 kg
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Afoxolaner
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
20-May-2019
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/19/240/007 |
28,3 mg |
1 |
PVH/Aclar/Al blisteris, 6 tablete |
-
|
|
|
Vectormune FP ILT
|
-
|
EU/2/20/266/003
|
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
-
|
chickens
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
lyophilisate and solvent for suspension for injection
|
| International name (active substance): |
Live recombinant fowlpox virus
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
| Date of authorisation/renewal: |
09-Dec-2020
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/20/266/003 |
|
5 |
Stikla flakons, 1000 devas/flakonā |
-
|
|
|
Bovilis Cryptium
|
-
|
EU/2/23/303/002
|
Intervet International B.V., Nīderlande
|
QI02AO02
|
Cattle (pregnant heifer); Cattle (pregnant cow)
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Cryptosporidium parvum, glycoprotein gp40
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
23-Nov-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/23/303/002 |
|
1 |
Stikla flakons, 10 ml |
-
|
|
|
Emevet
|
-
|
EU/2/25/343/012
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QA04AD90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Maropitant
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
02-Jun-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/343/012 |
|
10 |
Blisteris, 10 tablete |
-
|
|
|
Bravecto Plus
|
-
|
EU/2/18/224/004
|
Intervet International B.V., Nīderlande
|
QP54AB52
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Fluralaner
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Intervet UK Ltd, Lielbritānija
|
| Date of authorisation/renewal: |
08-May-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/18/224/004 |
|
2 |
PP/Al pipete, 0,89 ml |
-
|
|
|
Clevor
|
30 mg/ml
|
EU/2/17/222/002
|
Orion Corporation, Somija
|
QN04BC04
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
eye drops, solution
|
| International name (active substance): |
Ropinirole hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Orion Corporation, Somija
|
| Date of authorisation/renewal: |
09-Mar-2023
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/222/002 |
30 mg/ml |
2 |
ZBPE flakons, 0,6 ml |
-
|
|
|
Firocoxib CP-Pharma
|
57 mg
|
EU/2/25/359/003
|
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
CP-Pharma Handelsgesellschaft GmbH, Vācija
|
| Date of authorisation/renewal: |
26-Jan-2026
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/25/359/003 |
|
30 |
alumīnija/PVC/PE/PVDC blisteris, 10 tablete |
-
|
|
|
Suvaxyn Circo
|
-
|
EU/2/17/223/002
|
Zoetis Belgium S.A., Beļģija
|
QI09AA
|
fattening pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated porcine circovirus with type 2 ORF2 protein
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
07-Feb-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/17/223/002 |
50 deva |
1 |
Polietilēna flakons, 100 ml |
-
|
|
|
Vectra 3D
|
-
|
EU/2/13/156/021
|
Ceva Sante Animale, Francija
|
QP53AC54
|
very large dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Permethrin,Pyriproxyfen,Dinotefuran
|
| Distribution category: |
Nonprescription veterinary medicinal product
|
| Manufacturer(s) responsible for batch release |
Ceva Sante Animale, Francija
|
| Date of authorisation/renewal: |
27-Aug-2018
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/13/156/021 |
|
1 |
Pipete, 1 deva |
-
|
|
|
TOLFENAMIC ACID VMD
|
40 mg/ml
|
EU/2/24/329/001
|
V.M.D. n.v., Beļģija
|
QM01AG02
|
cattle; pigs; dogs; cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Tolfenamic acid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
03-Feb-2025
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/329/001 |
40 mg/ml |
1 |
Stikla flakons, 25 ml |
-
|
|
|
Advocate Spot-on šķīdums maziem suņiem
|
-
|
EU/2/03/039/005
|
Bayer Animal Health , Vācija
|
QP54AB52
|
small dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Moxidectin,Imidacloprid
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
KVP Pharma + Veterinar Produkte GmbH, Vācija
|
| Date of authorisation/renewal: |
01-Apr-2003
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/03/039/005 |
|
3 |
Pipete, 1 deva |
-
|
|
|
Stronghold
|
60 mg
|
EU/2/99/014/013
|
Zoetis Belgium S.A., Beļģija
|
QP54AA05
|
cats
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
spot-on solution
|
| International name (active substance): |
Selamectin
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Pfizer Service Company bvba, Beļģija
|
| Date of authorisation/renewal: |
07-Apr-2015
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/99/014/013 |
60 mg/ml |
3 |
Polipropilēna pipete, 1 deva |
-
|
|
|
Cirbloc M Hyo
|
-
|
EU/2/24/322/007
|
Ceva-Phylaxia Veterinary Biologicals Co. Ltd., Ungārija
|
QI09AL08
|
fattening pigs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
emulsion for injection
|
| International name (active substance): |
Inactivated Mycoplasma hyopneumoniae, strain 2940
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
-
|
| Date of authorisation/renewal: |
24-Oct-2024
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/24/322/007 |
|
6 |
ZBPE pudele, 250 ml |
-
|
|
|
Zenalpha
|
-
|
EU/2/21/279/001
|
Vetcare Oy, Somija
|
QN05CM99
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
solution for injection
|
| International name (active substance): |
Medetomidine hydrohloride, Vatinoxan hydrochloride
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Apotek Produktion & Laboratorier AB, Zviedrija
|
| Date of authorisation/renewal: |
15-Dec-2021
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/21/279/001 |
|
1 |
Stikla flakons, 10 ml |
-
|
|
|
Previcox
|
57 mg
|
EU/2/04/045/008
|
Boehringer Ingelheim Vetmedica GmbH, Vācija
|
QM01AH90
|
dogs
|
Vairāk
|
Medicinal product information
| Pharmaceutical form: |
chewable tablets
|
| International name (active substance): |
Firocoxib
|
| Distribution category: |
To be supplied only on veterinary prescription
|
| Manufacturer(s) responsible for batch release |
Merial, Francija
|
| Date of authorisation/renewal: |
29-May-2009
|
| Marketing authorisation valid until: |
Unlimited time period
|
| Marketing authorisation procedure: |
EU
|
| Package leaflet: |
*
-
|
| Labelling text: |
*
-
|
| Summary of product characteristics: |
*
-
|
|
*
More detailed information available on the European Medicines Agency website
|
Products
| ID |
Strength |
Package size |
Primary packaging |
Labelling |
| EU/2/04/045/008 |
57 mg |
1 |
Polietilēna pudele, 60 tablete |
-
|
|